BioAge Labs, Inc. Liquidation Value

BIOA Other

Cash & Equivalents

$188.89M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $188.89M
Total Obligations: -$23.05M
$165.84M
Per share: $4.44
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $188.89M
AR: $769,000
Total Obligations: -$23.05M
$166.61M
Per share: $4.46
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $188.89M
AR: $769,000
Inventory: $0
Total Obligations: -$23.05M
$166.61M
Per share: $4.46
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$165.84M$4.44
Liquid Liquidation Value$166.61M$4.46
Operating Liquidation Value$166.61M$4.46

Key Components (as of 2025-12-31)

Cash & Equivalents$188.89M
Accounts Receivable$769,000
InventoryN/A
Current Liabilities$20.14M
Long-term Debt$0
Op. Lease Liability$2.91M
Finance LeaseN/A
Shares Outstanding37.4M

Explore all 179 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$188.89M$769,000N/A$2.67M$20.14M$0$2.91MN/A
2025-09-30$215.57M$515,000N/A$5.02M$24.49M$0$3.01MN/A
2025-06-30$220.33M$603,000N/A$1.33M$22.84M$0$3.15MN/A
2025-03-31$257.49M$361,000N/A$3.99M$23.74M$7.06M$3.26MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-03-24 View
2025-09-30 10-Q 2025-11-06 View
2025-06-30 10-Q 2025-08-06 View
2025-03-31 10-Q 2025-05-06 View
2024-12-31 10-K 2025-03-20 View
2024-09-30 10-Q 2024-11-07 View

Community Notes

Loading notes...

Questions

Loading questions...